Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Milne

Showing results (681-690 of 992) with videos related to

Pageof 100
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2020
Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell NeoplasmsAmedeo Gagliardi, Pierre-Antoine Dugué, Therese H Nøst, et al.
Molecular Oncology|December 3, 2014
Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patientsMarta M Kamieniak, Daniel Rico, Roger L Milne, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
International Journal of Epidemiology|March 9, 2018
Genome-wide average DNA methylation is determined in uteroShuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
Scientific Reports|November 28, 2017
Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylationGiovanni Fiorito, Silvia Polidoro, Pierre-Antoine Dugué, et al.
International Journal of Obesity (2005)|December 27, 2017
Novel associations between blood DNA methylation and body mass index in middle-aged and older adultsY M Geurts, P-A Dugué, J E Joo, et al.
Breast Cancer Research and Treatment|April 17, 2009
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersRoger L Milne, Ana Osorio, Teresa Ramón y Cajal, et al.
Pageof 100

Showing results (681-690 of 992) with videos related to

Sort By:
Pageof 100
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2020
Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell NeoplasmsAmedeo Gagliardi, Pierre-Antoine Dugué, Therese H Nøst, et al.
Molecular Oncology|December 3, 2014
Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patientsMarta M Kamieniak, Daniel Rico, Roger L Milne, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
International Journal of Epidemiology|March 9, 2018
Genome-wide average DNA methylation is determined in uteroShuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
Scientific Reports|November 28, 2017
Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylationGiovanni Fiorito, Silvia Polidoro, Pierre-Antoine Dugué, et al.
International Journal of Obesity (2005)|December 27, 2017
Novel associations between blood DNA methylation and body mass index in middle-aged and older adultsY M Geurts, P-A Dugué, J E Joo, et al.
Breast Cancer Research and Treatment|April 17, 2009
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersRoger L Milne, Ana Osorio, Teresa Ramón y Cajal, et al.
Pageof 100